@article{5c794faf1c3c4826bcf882eaf296c78f,
title = "Letter: loss of response to anti-TNFα agents in patients with inflammatory bowel disease depends on treatment duration",
author = "Shomron Ben-Horin and Bella Ungar",
note = "Funding Information: Declaration of personal interests: Shomron Ben-Horin has received advisory board and/or consulting fees from Abbvie, Takeda, Janssen, Celltrion, Pfizer, GSK, Ferring, Novartis, Roche, Gilead, NeoPharm, Predicta Med, Galmed, Medial Earlysign, and Eli Lilly, options in Predicta Med, Evinature & Galmed, and research support from Abbvie, Takeda, Janssen, Celltrion, Pfizer, & Galmed. Bella Ungar received consultation fees from Neopharm, Takeda, Janssen and Abbvie.",
year = "2022",
month = feb,
doi = "10.1111/apt.16713",
language = "אנגלית",
volume = "55",
pages = "497--498",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",
}
